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Edited by P. WrightAbstractCooperativity of ligand binding to allosteric receptors can be quantified using the Hill coefficient (nH) to
measure the sigmoidal character of the binding curve. However, for measurements of the transition between
conformational states, nH values can be misleading due to ambiguity of the reference state. For cooperative
ligand binding, the reference state is a hyperbolic curve for a monomer with a single binding site characterized
by nH=1. Therefore, binding curves with nHN1 provide a direct measure of cooperativity. For the dependence
of the conformational state on ligand concentration, curves with nHN1 are observed, but in virtually all cases,
the equivalent allosteric monomer has a value of nHb1. The ratio of the two nH values defines the effective
cooperativity and always corresponds to nH=N (the number of protomers in the oligomer) for concerted
transitions as specified by the Monod–Wyman–Changeux model. Dose–response curves for homopenta-
meric α7 nicotinic receptors illustrate this relationship for both wild-type and mutant forms. For functional
allosteric monomers such as G-protein-coupled receptors, normalization stretches the dose–response curve
along the y-axis, thereby masking the “allosteric range” and increasing the apparent cooperativity to a limit for
monomers of nH =1. The concepts of equivalent monomer and allosteric range were originally proposed in
1965 by Crick and Wyman in a manuscript circulated among the proponents of allostery, but only now
published for the first time in this special issue.
© 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.Introduction
Understanding the molecular basis of cooperative
interactions has been an active research subject
since observations in the early 20th century described
the sigmoidal curve for oxygen binding by hemoglo-
bin, designated “heme–heme interactions.” A simple
explanation for heme–heme interactions of hemoglo-
bin was proposed by A.V. Hill in 1910 based on the
hypothesis that an integral number, n, of oxygen
molecules bind simultaneously to hemoglobin.1 For
example, when the fractional oxygen binding, Y , is
presented in the form of a “Hill plot,” that is,
log Y= 1−Y
  
versus log [O2], the sigmoidal curve
is linearized and the slope at Y =0.5 provides an
index of cooperativity known as the Hill coefficient, nH,
with a value for hemoglobin typically of nH~3. The
corresponding curve for myoglobin with a single
heme for binding oxygen is hyperbolic and in a Hill
plot yields a slope of nH=1, which sets the lower limit
of positive cooperativity. Heme–heme interactions
are important physiologically, because hemoglobin is0022-2836 © 2013 Elsevier Ltd. Open access under CC BY-NC-ND licenearly saturated by oxygen at the partial oxygen
pressure in the capillaries of the lung, while a
substantial fraction of the bound oxygen is released
at the partial oxygen pressure in the capillaries near
active muscle. In contrast, were hemoglobin
replaced by myoglobin in vertebrate red blood
cells, saturation in the lungs would be complete,
but only a small fraction of the bound oxygen would
be released.
The pioneering work of Adair in 1925 established
that hemoglobin contains four oxygen-binding heme
sites.2 Therefore, the Hill coefficient does not
describe the mechanism of oxygen binding, since
the value of nH~3 would imply three rather than four
hemes, but the Hill coefficient is nevertheless a
useful index of cooperativity on a scale from 1 to N
(the number of binding sites and hence the
theoretical upper limit to nH). Adair also determined
values for the four phenomenological oxygen bind-
ing constants that describe the sigmoidal curve but
did not propose a mechanistic model to explain the
increase in affinity as oxygen binding proceeds.3J. Mol. Biol. (2013) 425, 1424–1432nse.
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tetramers was proposed by Pauling in 1935 based
on interactions between the four sites that are
progressively stabilized as oxygen is bound.4 His
equations provided the basis for the sequential
Koshland–Nemethy–Filmer model, which postulated
a ligand-induced conformation change upon oxygen
binding to each subunit.5
A turning point in the research on hemoglobin
occurred when Perutz and Kendrew provided the
first crystal structures of hemoglobin and myoglo-
bin, revealing the close resemblance of each of the
four hemoglobin subunits (two α chains and two β
chains) to single-chain myoglobin.6,7 Moreover,
pursuing the observation of different crystal forms
in the presence and absence of oxygen by
Haurowitz in 1938, Muirhead and Perutz estab-
lished the structures of the two distinct forms for
liganded hemoglobin and deoxyhemoglobin.8
Beginning in the 1950s, cooperative interactions
were also observed in studies of the kinetics of
feed-back inhibited enzymes,9–11 as well as for
dose–response phenomena of receptor–ligand
interactions.12,13 The notion of “cooperative interac-
tions” based on the Hill coefficient was applied to
enzymes and receptors, although for certain physio-
logical processes, the related terms “ultrasensitivity”
and “supralinearity” have also been employed.14,15
Introducing the concept of “allosteric interactions”
provided an important step in the understanding of
the nature of cooperative interactions and their
modulation by effectors binding at allosteric sites
that are structurally distinct from the active site.16–18
A particularly fruitful model for cooperative interac-
tions to develop further this concept was proposed
by Monod, Wyman, and Changeux.19 The Monod–
Wyman–Changeux (MWC) model postulates a
spontaneous, concerted equilibrium between two
symmetric, oligomeric conformational states, the
high-affinity R state and the low-affinity T state.
The distribution between the two states is set by their
intrinsic interconversion equilibrium in the absence
of ligand specified by L, the allosteric constant,
where L= [T]/[R]. As applied to hemoglobin, the
model provided a simple explanation for cooperative
oxygen binding based entirely on only the two
conformational states of Perutz. Extensions of the
MWC model also explained the paradoxical result
that mutant hemoglobins with either very high or very
low affinities display very low cooperativity. The
high-affinity mutants are hyper-stabilized in the R
state, whereas the low-affinity mutants are hyper-
stabilized in the T state, with cooperativity greatly
diminished in both cases.20
A salient feature of the MWC model concerns
differences in Y , the binding function, compared to
R , the state function, defined as the fraction of
molecules in the R state. In contrast to the Kosh-
land–Nemethy–Filmer model, the two functions donot necessarily superimpose and this distinction was
an important element in support of the MWC model,
for example, in early studies on the enzyme
aspartate transcarbamylase. In this case, the bind-
ing of the substrate analog succinate under the
conditions examined is cooperative with a value for
Y of nH~1.5. Under the same conditions, measure-
ment of the conformational transition,R , by changes
in the sedimentation coefficient or PMB reactivity
produced a sigmoidal curve significantly to the left of
Y .21 More recent work on the bacterial flagellar
motor has revealed even more striking differences
between in Y and R .14,22,23
Equilibrium curves for R as a function of ligand
concentration are measured by monitoring a confor-
mational probe or functional assay [i.e., ion flow for a
ligand-gated channel or downstream response for a
G-protein-coupled receptor (GPCR)]. Although the
analysis of cooperativity based on the Hill coefficient
is often applied to receptors, the applications to
dose–response phenomena are complicated by end
points that are not at 0 and 1. In contrast to ligand
binding measurements with values of Y strictly from
0 and 1, the R values for conformational transitions
as formulated by the MWC model fall into the range
between RminN0 in the absence of ligand and
Rmaxb1 under conditions of ligand saturation. The
concept Q, the “allosteric range,” where Q=Rmax−
Rmin, was initially introduced in a 1965manuscript by
Crick and Wyman, which is published for the first
time in this special edition.24 Applications of Q were
further refined by Rubin and Changeux.25 Since
absolute values of Rmin and Rmax are not readily
determined experimentally, data are commonly
normalized to a scale of 0–1, but the resulting
stretching in the vertical direction enhances the
apparent cooperativity.
While normalization can clearly distort the mea-
surement of cooperativity, interpretations of the true
cooperativity of allosteric transitions also require
comparison to a monomeric reference state. This
point was emphasized in the manuscript by Crick
and Wyman by postulating an “equivalent mono-
mer” that can undergo transitions between two
states, while emphasizing “that the equivalent
monomer is a mathematical fiction and is not the
actual monomer to which the oligomer may
dissociate.”24 The “equivalent monomer” is thus
distinct from a “functional monomer” that may exist
in solution, as in the case of lamprey hemoglobin,
which is largely dissociated in the oxygenated
state.26 For mammalian hemoglobins, similar con-
siderations apply, but at the level between tetra-
mers and dimers, since α2β2 hemoglobin in both
the T state and the R state dissociates to high-
affinity, non-cooperative αβ dimers.27 Functional
monomers also provide the basis of allosteric lattice
models since the energy of interaction between
monomers differs for the T and R states.23,28
1426 Review: Cooperativity of Allosteric ReceptorsIndeed, the concept of quaternary constraint is
essential in the MWC formulation for which each
protomer is constrained by quaternary bonds in T,
in comparison to weaker quaternary bonds in the
“relaxed” R state. In contrast, with respect to Crick–
Wyman equivalent monomers, the interaction en-
ergies within the oligomeric states are strictly
identical, as in the applications we have recently
described.29 As we elaborate further here, hypo-
thetical conformational transitions for equivalent
monomers serve as reference states to measure
the cooperativity of oligomeric allosteric proteins.
Considerations of allosteric monomers are further
complicated by adding non-symmetric intermediate
states to the MWC model in which individual
subunits may occupy a tertiary conformation distinct
from the quaternary conformation.30–33 Therefore,
problems of nomenclature and definition must be
addressed to avoid confusions arising from attribut-
ing distinct allosteric roles to monomer units under
widely different circumstances. Once they are
properly characterized, considering hypothetical
equivalent monomers aids in revealing the precise
degree of cooperativity for conformational transitions
of oligomeric allosteric proteins. More directly,
equivalent monomers can provide insights for stable
functional monomers, such as monomeric GPCRs,
in relation to dose–response data, as well as
conformational selection of other monomeric pro-
teins as examined recently.34–36 However, it is
important to distinguish the concepts of hypothetical
equivalent monomers versus physically real func-
tional monomers that may play a significant role for
allosteric proteins in certain cases. For this reason,
we introduce specific nomenclature for the two
cases as described in the following section. The
contrasting implications for equivalent and functional
monomers are also considered in Discussion,
including presentation of distinct energy diagrams.Conformational Equilibria of Equivalent
Monomers versus Functional Monomers
While a single-chain protein such as myoglobin
provides an unambiguous non-cooperative reference
state for comparison with hemoglobin, interpretations
are less straightforward for conformational changes
measured by R or for dose–response behavior in
general. In contrast to the use of the Hill coefficient
to assess Y , R changes in the conformational state
as described by the MWC model with interconver-
sion between two symmetrical states are always
fully concerted. Hence, the true cooperativity of R is
always given by N, the number of subunits.29 For
measurements under experimental conditions, the
apparent cooperativity can only be evaluated with
respect to conformational transitions of equivalent
monomeric reference states. Efforts to relate thesestates to the oligomeric T and R states have taken
various forms, including designating the monomer
states and their interconversion by lowercase letters,
that is, replacing R, T, and L by r, t, and l,
respectively.24,33 While logical, this nomenclature
can lead to confusions in spoken language. More-
over, it is important to distinguish between hypo-
thetical equivalent monomers (“a mathematical
fiction,” as noted above) and physically plausible
functional monomers. For this reason, we propose a
distinct nomenclature for the two cases and adopt λ
for the allosteric transition of equivalent monomers,
as we previously applied, to mark a clear distinction
with L.29 By analogy, we designate furthermore the
equivalent monomers corresponding to the T and R
states by the Greek letters tau and rho, s and ρ,
respectively, producing λ=[s]/[ρ]. Concerning func-
tional monomers, we propose representation of the
conformational change at the monomer level in
terms of two monomeric states by T* and R* (read
as “T-star” and “R-star”) corresponding to the
oligomeric states T and R, while emphasizing that
this nomenclature is distinct from an earlier usage
we made for these terms.29 The equilibrium
between T* and R* is defined by a monomeric
allosteric constant, L*, where L*= [T*]/[R*]. The
functional monomer is assumed to possess a single
ligand binding site; as a result, single-polypeptide
proteins with multiple sites, such as calmodulin,
would not be included, and as allosteric proteins,
they must be treated as heterotetramers.37 For both
the equivalent monomeric states, s and ρ, as well as
the functional monomeric states T* and R*, we
assume that they share the same respective
affinities for each ligand considered, as do T and
R. Finally, we propose retaining the terms t and r
solely to designate the tertiary conformation with a
quaternary state.33
Based on linkage principles, the relationship of
the allosteric constant, L, corresponding to T and R
oligomeric states with N identical subunits with
respect to equivalent monomers is given by L=
λN.24,29 However, the equation L=λN requires
identical energies of interaction between protomers
in the T and R states, with no particular re-
quirements for their magnitudes (other than the
implicit requirement that the T and R states are
stable oligomers). This formulation of identical
stabilities for T and R, while useful for certain
applications (see below), departs from the underly-
ing principle of “quaternary constraint,” which
implies stronger protomer interactions within the T
state compared to the R state, as pointed out by
Monod in an unpublished response to the manu-
script of Crick and Wyman.38 Hence, a more
physically realistic expression for a functional
monomer would take the form L= (L*)N(KN,1
R /KN,1
T ),
where KN,1
R and KN,1
T are the oligomer-to-monomer
dissociation equilibrium constants for the R and T
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Fig. 1. Dependence of cooperativity on Q and λ for
hypothetical allosteric monomers. (a) A series of R curves
without normalization for decreasing values of c in steps of
0.25 to produce the series of c values: 0.7, 0.175, 0.044,
0.011, 0.00275, with each curve calculated with a value of
λ ¼ 1= ﬃﬃﬃcp . Under these conditions, the curves all exhibit a
midpoint of R =0.5. The individual values of nH at the
midpoint range from 0.09 to 0.9. When individual values of
nH for the curves are plotted against the corresponding
value ofQ, a direct correspondence is observed, as shown
in the inset. The values ofQ=Rmax−Rmin are illustrated for
the limits of the R curve for c=0.7, with the limits for the
other curves calculated with similar principles. (b) The
series of R curves in (a) with normalization applied,
yielding nH=1.0 in all cases. The ligand concentration is
represented by α, where α=[ACh]/KR and KR is the affinity
of the ligand for the R state.
1427Review: Cooperativity of Allosteric Receptorsstates, respectively, and N is the number of
monomers (also referred to as protomers) in the
oligomer. Fundamentally, the energy difference
between the T and R states implied by LN1 can
arise in two different ways. The hypothetical
equivalent monomer of Crick and Wyman repre-
sents the protomer within the oligomer, with all the
transition energy of the oligomer coming from the
transition energy of the monomers. In contrast,
Monod's functional monomer represents the free
protomer, with the transition energy of the oligomer
arising both from the transition energy of the
monomers and from stronger inter-subunit interac-
tion in the T state (see Discussion).
With these concepts in mind, we can return to the
evaluation of cooperativity of R . The degree of
cooperativity can be estimated directly by the
derivative of R curve, and for this purpose, we have
assigned the Greek letter ν (nu), where ν=dR /d[X]
and [X] is the concentration of ligand.29 The more
familiar Hill coefficient can also be used as an
empirical measure but will yield reliable results only
when judiciously applied to take into account the
allosteric range and the relationship to equivalent
monomers in the light of the following considerations.
Concerning the allosteric range, the principal
difficulty for use of the Hill coefficient with R
measurements is the determination of end points.
For ligand binding, measurements ofY performed by
direct experimental methods fix the end points of
binding data, since values are readily established at
Y =0 in the absence of ligand andY =1 at saturating
concentrations of ligand. For measurements of R ,
the reading at zero ligand concentration for whatever
signal is being monitored reflects a mixture of T and
R states, with Rmin=1/(1+L). Thus, for values of
Lb100, a significant fraction of molecules will be
present in the R state even in the absence of ligand.
Similarly at saturating concentrations of ligand, a
significant fraction of molecules may be present in
the T state, since R b1. The exact value is given by
Rmax=1/(1+Lc
N), where c is the ratio of ligand
dissociation constants of the R and T states (c=KR/
KTb1) and N is the number of ligand binding
sites.24,25,39
Variations in Rmin and Rmax are illustrated for a
series of curves with increasing values of the
allosteric parameter c (Fig. 1a). For each curve, the
corresponding value of λ is fixed byλ ¼ 1= ﬃﬃﬃcp . Under
these conditions, all of the curves are symmetric
about their midpoint at R =0.5. Since the end points
for R measurements are fixed by RminN0 and
Rmaxb1, the value of the Hill coefficient for any
experimentally determined data set will depend on
the precise estimation of the end points. This feature
of cooperativity is directly related to the allosteric
range, Q=Rmax−Rminb1.24,25 For allosteric mono-
mers as described in Fig. 1a, the relationship
between cooperativity and allosteric range is simpleand nH=Q, as shown in Fig. 1a (inset). Moreover, for
any R (or dose–response) curve for monomers
normalized to the range 0–1, the corresponding
value of the Hill coefficient will necessarily be nH=1,
as shown in Fig. 1b for the data from Fig. 1a after
normalization. Allosteric modulators can influence Q
by altering λ (or L for oligomers), but the changes can
only be ascertained clearly for data that are not
normalized.
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Fig. 2. Properties of α7 nicotinic receptors wild-type and
V251T mutant. (a) Dose–response ( R ) curves with
normalization. (b) Dose–response ( R ) curves without
normalization. The concentration of acetylcholine is
represented by α, where α= [ACh]/KR. Curves were
calculated using data presented previously.43 In (b), the
cooperativity of each curve is evaluated at the points
1428 Review: Cooperativity of Allosteric ReceptorsReevaluating Cooperativity for α7
Nicotinic Receptors based on
Equivalent Monomers
The importance of the equivalent monomers
concept can be illustrated by considering published
data for nicotinic receptors, particularly α7 homo-
pentamers. Mutations introduced in the gene of α7
corresponding to residues lining the ion channel
have been shown to exhibit dramatic gain-of-
function phenotypes.40–42 For example, V251T
displays a dose–response curve shifted to the left
(EC50=0.002 mM versus 0.1 mM for wild type), with
higher cooperativity (nH=2.1 versus 1.3 for wild
type). Analysis in terms of the MWC model revealed
that these gain-of-function properties could be
explained by a substantial reduction in the value of
the allosteric constant L.43,44 The initial analysis was
based on normalized curves as presented in Fig. 2a,
with the values of nH noted above. However, when
the same data are presented without normalization
and curves for the corresponding equivalent mono-
mers are added in Fig. 2b, major differences are
observed. Cooperativity is unaltered for V251T by
normalization because the allosteric range without
normalization is close to 1. In contrast, for the wild-
type curves, cooperativity without normalization is
only nH=0.7, much lower than the normalized value
of 1.3. Examination of the cooperativity of the
equivalent monomers at the same values of α at
which the nH of the pentamers were determined
gives values of nH=0.42 (V251T) and 0.14 (wild
type). Clearly, in both cases, the ratio of pentamer/
monomer values is exactly 5.0, in accord with the
argument presented above that the intrinsic coop-
erativity of conformational transitions for the two
states of allosteric oligomers must be equal to the
number of subunits.indicated by the pair of dashed vertical lines, with values of
nH=2.1 and 0.42 for V251T pentamers and equivalent
monomers, respectively, and nH=0.7 and 0.014 for wild-
type pentamers and equivalent monomers, respectively.
The value of nH for the wild-type equivalent monomers is
calculated at the value of α corresponding to the midpoint
of the R curve for wild-type pentamers to permit exact
comparison. At the midpoint of the R curve for wild-type
monomers (★), nH=0.47. Parameter values are c=0.1 for
all curves; V251T: λ=1.82 (L=λ5=20); wild type: λ=15.2
(L=λ5=8×105).Discussion
By revisiting concepts formulated at the early stages
of allostery, their impact on recent observations canbe
examined. This is particularly fruitful for the exchange
initiated in 1965 by Crick and Wyman in reaction to a
footnote on page 115 of the MWC article in which the
properties of a tetramer and a monomer were
compared using the same L value for both. The
Crick–Wyman text “A Footnote on Allostery” was
originally intended for publication, but as exchanges
progressed and Monod drafted “A Third-power
Footnote to Allosteric Transitions” for which he
planned to associate Changeux and Wyman as co-
authors, the impetus to publish waned and the texts
never advanced beyond the “unpublished” status. Up
to now, the texts and the lively exchanges in related
letters were only available in archives of the pro-tagonists' papers at the Wellcome Library, Harvard
University, and the Pasteur Institute, but the original
manuscript of Crick and Wyman was judged to be of
sufficient interest for historical and practical reasons to
publish it now in this volume, nearly a half-century after
it was drafted.24 In the associated letters between
1429Review: Cooperativity of Allosteric ReceptorsMonod and Crick, the humor, camaraderie, and
obvious pleasure of friendly disputation are fully in
evidence as they debate conflicting intentions to
“Mother Nature.” Some aspects of the exchange
have been discussed previously in the context of a
wider examination of the interactions between Monod
and Wyman, and they are further developed in the
article in this volume by H. Buc.45
Since the intentions of Mother Nature remain moot
points, the importance for posterity lies in the concepts
of equivalent monomer and allosteric range first
suggested by Crick and Wyman. With respect to the
former, the principle contribution of Monod was to
emphasize that the relationship between monomer
and oligomer summarized by the equation L=λN
requires identical inter-monomer binding energies for
theTandRstates. In otherwords,λ is fixedbyλ ¼ ﬃﬃﬃLNp .
For this reason, we also defined a distinct relationship,
as discussed above, that would apply to a functional
monomer,with amonomer allosteric constant given by
L* involving in addition distinct interaction energies
between protomers of the R and T states. As
emphasized in the MWC article, the physical basis of
the allosteric model is the tighter interactions between
protomers in theTstate than in theRstate, constituting
the concept of “quaternary constraint.”19 In this case,
L=(L*)N(KN,1
R /KN,1
T ), as defined earlier in this text. In
contrast to λ, which depends exclusively on L and
N, the relationship between λ and L* is then given
by λ ¼ Lð *Þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
KN;1
R=KN;1
T Nq . In other terms, the
energy of conformational transition for the equiva-
lent monomer is equal to the sum of the energy of the
conformational transition for the functional monomer
plus the difference in the binding energies of the
monomers in the oligomer.R
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monomers in the right panel. For the T state, on the left, the
indicated by (a), is identical with the constant for R state disso
relationship L=λN. In contrast, on the right panel, the dissociati
stronger interactions, that is, (a′)N (b′). In this case, L≫1, but
indicated using standard thermodynamic values.46 The T statA graphical representation of the distinctions
between equivalent monomers and functional mono-
mers is presented in Fig. 3 in terms of free-energy
differences for the two cases. In the case of
equivalent monomers, the energy of stabilization of
the unliganded oligomeric T state compared to the R
state is precisely N times the energy of stabilization
of the monomeric unliganded τ state compared to the
ρ state, but the energy difference between mono-
mers and oligomers is never defined, other than to
assume it is large enough to stabilize the oligomers
at physiological concentrations. In the case of
functional monomers, for the hypothetical parameter
values selected, the unliganded oligomeric T state is
more stable than the R state, but in keeping with the
concepts of “quaternary stability” and the “relaxed”
condition of the R state, at the monomeric level, R* is
more stable than T*.
The concepts of allosteric range and equivalent
monomer are particularly relevant for allosteric re-
ceptors, since their functional properties are generally
quantitated by dose–response measurements direct-
ly related to R , in comparison to enzymes or binding
proteins such as hemoglobin more commonly char-
acterized with respect to Y . For estimations of the
degree of cooperativity for dose–response data, the
concept of allosteric range is indispensable in order to
recognize the consequences of normalization of the
experimental results, which increases the estimated
value of the Hill coefficient nH by vertical stretching of
the data. This effect was illustrated for data obtained
for α7 nicotinic receptors (Fig. 2), for which normal-
ization increased the apparent value of nH for wild-
type receptors from 0.7 to 1.3. It is therefore important
to recognize the distinctions arising from normaliza-
tion. These effects can be contrasted to stretching 
R
 
(b’) 
T
 
-RT log TKN,1 ’) 
-RT log L
-N (RT log L*)
N R
 
* 
(a’) > (b’) 
L = (L* )
 
  (RKN,1 /  TKN,1) 
-RT log RKN,1 
Monomers 
N 
Oligomers 
 T
 
*  
Functional  Monomers: T* & R*  
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ciation to ρ monomers, that is, (a)= (b), as required by the
on constant for the T state, indicated by (a′), corresponds to
L*b1. Energies are calculated for the various parameters
e is in blue and the R state is in green.
1430 Review: Cooperativity of Allosteric Receptorsalong the horizontal axis due to ligand depletion,
which can reduce the apparent cooperativity.29
Considerations of multiple effectors binding to an
allosteric protein can also lead to the opposite effect
of contraction of the horizontal axis due to accretion of
sequestered ligands.47
While many of the concepts presented here are of
theoretical interest, applications to monomeric forms
of GPCRs may be of more practical concern,
particularly with respect to models of functional
monomers rather than equivalent monomers. Al-
though the range of GPCR is vast, many common
properties appear across the spectrum of
diversity.48 Special features of GPCRs must be
taken into account such as multiple conformational
states with distinct functions and ligands with distinct
signaling profiles.49–51 In addition, various forms of
homo- and hetero-oligomerization are involved and
can alter the dynamic range because oligomeriza-
tion increases the L value.52–54 The concept of
dynamic range to interpret data without normaliza-
tion is reflected by the importance of inverse
agonists and related effects produced by modulators
that act at allosteric sites.54–56 Similar reasoning
leads to the understanding that ligand molecules
with apparent properties of competitive agonists in
systems with high L values can be revealed to be
partial agonists at lower L value.43 Constitutively
active GPCRs confirm the presence of preexisting
allosteric equilibria between conformations, provid-
ing insights into both normal and pathological
receptors.56–58 GPCRs are therefore a rich source
for extensions of the allosteric principles, particularly
in the light of recent advances in structural studies.59
Future developments of allostery in the domain of
GPCRs are likely to bring additional insights.Acknowledgement
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